Pathophysiology and management of transformed migraine and medication overuse headache
- PMID: 16628534
- DOI: 10.1055/s-2006-939924
Pathophysiology and management of transformed migraine and medication overuse headache
Abstract
There is considerable overlap in the mechanisms mediating migraine headache pain and sustained opioid-induced paradoxical pain. Both involve upregulation of calcitonin gene-related peptide and increased excitability of dorsal horn neurons. Descending facilitation from the rostral ventromedial medulla may contribute to this increased excitability. Using special magnetic resonance imaging techniques, high iron levels were found in the periaqueductal gray of patients with chronic daily headache with medication overuse. The periaqueductal gray is the center of a powerful descending antinociceptive neuronal network and projects to the rostral ventromedial medulla and subsequently to the dorsal horn. The periaqueductal gray is also involved in the behavioral response to opiate withdrawal. Dysfunction in the periaqueductal gray may explain why frequent analgesic use can result in medication overuse headache in migraineurs. Management of transformed migraine with medication overuse involves patient education, biobehavioral therapy, withdrawal of overused acute medications, bridge therapy for withdrawal headache, initiation of preventive medication, and close follow-up.
Similar articles
-
Similarities and differences between chronic migraine and episodic migraine.Headache. 2007 Jan;47(1):65-72. doi: 10.1111/j.1526-4610.2006.00629.x. Headache. 2007. PMID: 17355496
-
Pathophysiology of chronic migraine and mode of action of preventive medications.Headache. 2011 Jul-Aug;51 Suppl 2:84-92. doi: 10.1111/j.1526-4610.2011.01955.x. Headache. 2011. PMID: 21770930
-
Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine.Brain. 2006 Feb;129(Pt 2):543-50. doi: 10.1093/brain/awh691. Epub 2005 Dec 5. Brain. 2006. PMID: 16330505
-
Medication overuse headache.Prim Care. 2004 Jun;31(2):369-80, vii. doi: 10.1016/j.pop.2004.02.008. Prim Care. 2004. PMID: 15172512 Review.
-
Clinical features and therapy of medication overuse headache.Eur J Med Res. 2004 Dec 22;9(12):565-9. Eur J Med Res. 2004. PMID: 15689304 Review.
Cited by
-
[Brain iron deposition increases in the bilateral substantia nigra of patients with medication-overuse headache: a quantitative susceptibility mapping analysis].Nan Fang Yi Ke Da Xue Xue Bao. 2023 Nov 20;43(11):1833-1838. doi: 10.12122/j.issn.1673-4254.2023.11.01. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 38081599 Free PMC article.
-
Headache disorders: differentiating and managing the common subtypes.Br J Pain. 2012 Aug;6(3):124-32. doi: 10.1177/2049463712459691. Br J Pain. 2012. PMID: 26516483 Free PMC article.
-
Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.J Clin Neurol. 2011 Sep;7(3):143-7. doi: 10.3988/jcn.2011.7.3.143. Epub 2011 Sep 29. J Clin Neurol. 2011. PMID: 22087208 Free PMC article.
-
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels.Eur J Clin Pharmacol. 2008 Jan;64(1):1-8. doi: 10.1007/s00228-007-0391-4. Epub 2007 Nov 15. Eur J Clin Pharmacol. 2008. PMID: 18004553
-
A narrative review on the management of medication overuse headache: the steep road from experience to evidence.J Headache Pain. 2009 Dec;10(6):407-17. doi: 10.1007/s10194-009-0159-6. Epub 2009 Oct 3. J Headache Pain. 2009. PMID: 19802522 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical